Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

Table 2 Summary of final panel judgements compared with IWGDF judgements for all IWGDF PAD recommendations

No	Problem	Desirable effects	Undesirable effects	Quality of evidence	Values	Balance of effects	Acceptability	Applicability/feasibility	Decision	Comment
1	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
2	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
3	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
4	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
5	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
6	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
7	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
8	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
9	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
10	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
11	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
12	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
13	+	+	+	+	+	+	+	?	Adapted	Adapted: assess equipment availability & availability of expertise
14	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
15	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
16	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening
17	+	+	+	+	+	+	+	+	Adopted	Adopted in ADAPTE screening

+, panel agreed with original IWGDF judgement; −, panel disagreed with original IWGDF judgement;?, panel unsure if agreed with original IWGDF judgement due to lack of IWGDF information on judgement; =, panel agreed with original IWGDF judgements during screening (see Table 1); QoE Quality of evidence

ISSN: 1757-1146